Guardant Health GH Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 256%+3.6pp | 252.4%+3.7pp | 248.7%+4.6pp | 244.1%+4.4pp | 239.7%+2.4pp | |
| Operating margin | -190.6%+17.3pp | -207.9%+15.5pp | -223.4%+25.4pp | -248.8%+23.8pp | -272.6%+29.1pp | |
| Net margin | -176.6%+13.7pp | -190.3%+16.7pp | -207%+29.8pp | -236.8%+26.3pp | -263.1%+22.5pp | |
| EBITDA margin | -173.5%+15.5pp | -189%+13.8pp | -202.8%+23.7pp | -226.5%+22.1pp | -248.6%+27.3pp | |
| Free cash flow margin | -107.5%+17.4pp | -125%+13.5pp | -138.4%+10.6pp | -149%+13.7pp | -162.7%+10.4pp | |
| Returns | ||||||
| Return on assets | -106.8%+0.7pp | -107.6%+2.9pp | -110.5%+2.4pp | -112.9%+0.3pp | -113.2%+1.3pp | |
| Efficiency | ||||||
| Asset turnover | 2.4×+0.2× | 2.3×+0.1× | 2.2×+0.2× | 1.9×+0.2× | 1.7×+0.1× | |
| Inventory turnover | 17.3×+0.4× | 16.8×+0.1× | 16.7×+0.4× | 16.3×+0.1× | 16.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 16.7×+0.6× | 16.2×+0.2× | 16×-2.7× | 18.7×-2.7× | 21.4×-1.8× | |
| Quick ratio | 15.4×+0.6× | 14.8×+0.2× | 14.6×-2.7× | 17.3×-2.7× | 20×-1.9× | |
| Cash ratio | 11.4×+0.2× | 11.2×-1.2× | 12.3×-0.6× | 12.9×-2.1× | 15×-1.6× | |
| Leverage | ||||||
| Debt-to-assets | 3.8×-0.1× | 3.9×-0.1× | 3.9×+0.9× | 3×+0.9× | 2.1×+0.9× | |
| Interest coverage | -494.6×+66.3× | -560.9×+59.7× | -620.6×+68.0× | -688.6×+48.0× | -736.6×+38.8× | |
| Per Share | ||||||
| Book value per share | -$7.47+7.9% | -$8.12+4.1% | -$8.46-38.5% | -$6.11-66.8% | -$3.66-240% | |
| Valuation | ||||||
| Market capitalization | $39.37B+21.1% | $32.51B+41.2% | $23.02B+27.5% | $18.05B+17.3% | $15.39B+21.7% | |
| Enterprise value | $42.43B+19.6% | $35.47B+39.3% | $25.46B+31.5% | $19.36B+26.8% | $15.27B+37.6% | |
| Price / sales | 40.8×+4.4× | 36.4×+8.4× | 28×+4.6× | 23.4×+2.0× | 21.5×+2.6× | |
| EV / sales | 44.1×+4.3× | 39.7×+8.7× | 31×+6.0× | 25.1×+4.0× | 21.1×+4.8× | |
| Free cash flow yield | -11.5%+3.8pp | -15.3%+5.5pp | -20.8%+6.4pp | -27.2%+4.1pp | -31.3%+6.2pp | |
| Earnings yield | -18.5%+4.3pp | -22.9%+8.4pp | -31.3%+13.0pp | -44.3%+7.2pp | -51.5%+10.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Guardant Health's profit margins?
- Guardant Health (GH) runs a 64.9% gross margin and a -41.4% operating margin, with a -40.1% net margin.
- Where do Guardant Health's ratios come from?
- Every ratio is computed from Guardant Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
